Role of neurohumoral control of the circulation in determining exercise capacity in patients with heart failure.
暂无分享,去创建一个
[1] T. Ryan,et al. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. , 1986, Journal of the American College of Cardiology.
[2] J. Cohn,et al. The Neurohumoral and Hemodynamic Response to Orthostatic Tilt in Patients with Congestive Heart Failure , 1983, Circulation.
[3] P. Korner,et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.
[4] S. Yusuf,et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.
[5] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[6] F. Tristani,et al. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. , 1987, Circulation.
[7] J. Cohn,et al. Relative attenuation of sympathetic drive during exercise in patients with congestive heart failure. , 1985, Journal of the American College of Cardiology.
[8] R. Wilson,et al. Evidence for Structural Sympathetic Reinnervation After Orthotopic Cardiac Transplantation in Humans , 1991, Circulation.
[9] A. Mark,et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.
[10] J. Cohn,et al. Prognosis of congestive heart failure and predictors of mortality. , 1988, The American journal of cardiology.
[11] J. Cohn,et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.
[12] L. Stevenson,et al. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. , 1990, Circulation.
[13] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[14] J. Cohn,et al. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. , 1983, Journal of the American College of Cardiology.
[15] J. Cohn,et al. Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure. , 1986, The American journal of cardiology.
[16] J. Cohn,et al. Cardiovascular and Neurohormonal Effects of Atrial Natriuretic Peptide in Conscious Dogs With and Without Chronic Left Ventricular Dysfunction , 1990, Journal of cardiovascular pharmacology.
[17] J. Cohn,et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.
[18] J. Cohn,et al. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.